Euflexxa 1% 20 MG/2 ML syringe 2ML
Ended Awarded
- Contract number
- SPE2DB25FGXUR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,963
Award facts
- Contract value 100% obligated
- $3,962.99 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Euflexxa 1% 20 mg/2 mL syringes with a ceiling value of $3,962.99 and an ultimate completion date of September 10, 2025. Euflexxa is a viscosupplement injection used to treat knee osteoarthritis pain. This is a firm fixed price delivery order with no set-aside designation, placed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal military and veteran healthcare procurement through the Defense Logistics Agency's Medical Supply Chain. As the prime contractor under the comprehensive global pharmaceutical support vehicle SPE2DX, the company supplies a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including medications, vaccines, syringes, and specialized medical devices. This delivery order represents a routine transaction within AmerisourceBergen's extensive federal contracting portfolio with the DLA, demonstrating its continued role as a primary supplier of medical commodities to U.S. defense and healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FGXUR?
SPE2DB25FGXUR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 9, 2025.
How much is contract SPE2DB25FGXUR worth?
The government has obligated $3,963 on SPE2DB25FGXUR.
Is contract SPE2DB25FGXUR an order under another contract?
Yes. SPE2DB25FGXUR is a delivery order under SPE2DB24D2213, an indefinite delivery contract.
Was contract SPE2DB25FGXUR competed?
The extent of competition for SPE2DB25FGXUR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award